FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Method involves exposing a cell population in the form of pore mechanical destruction of a cell membrane with subsequent exposure of pH from 5.4 to 5.6, in an amount and for a time effective to increase the number of cells in the cell suspension, which express pluripotency markers, with subsequent selection of cells expressing one or more pluripotency markers. Obtained cells are introduced into the spinal cord of the individual.
EFFECT: increasing the number of pluripotent cells in a population of non-embryonic differentiated somatic cells and recovering a nerve function in a subject with neurological damage.
7 cl, 9 tbl, 29 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OBTAINING PLURIPOTENT CELLS DE NOVO | 2013 |
|
RU2696071C2 |
| TRANSIENT CELLULAR REPROGRAMMING TO REVERSE CELL AGING | 2019 |
|
RU2801316C2 |
| METHOD FOR PRODUCING HIGH-QUALITY INDUCED PLURIPOTENT STEM CELLS (IPSC) | 2016 |
|
RU2721266C1 |
| METHOD OF PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS OBTAINED ACCORDING TO THIS METHOD | 2020 |
|
RU2823729C1 |
| METHOD FOR OBTAINING CELLS FROM DENTAL PULP | 2019 |
|
RU2795621C2 |
| NERVOUS SYSTEM CELLS EXPRESSING E4ORF1 OF ADENOVIRUS, AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2015 |
|
RU2745300C2 |
| SINGLE EMBRYO STEM CELL CULTURE | 2008 |
|
RU2473687C2 |
| METHOD FOR ISOLATION OF PLURIPOTENT STEM CELLS FROM UMBILICAL BLOOD EXPRESSING ZNF281 | 2010 |
|
RU2511417C2 |
| METHOD FOR OBTAINING BIOMEDICAL CELL PRODUCT FOR TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE AND AUTOIMMUNE DISEASES | 2019 |
|
RU2774350C2 |
| SUSPENDING AND CLUSTERING HUMAN PLURIPOTENT STEM CELLS FOR THEIR DIFFERENTIATION INTO PANCREATIC ENDOCRINE CELLS | 2014 |
|
RU2689710C2 |
